Old Web
English
Sign In
Acemap
>
Paper
>
EP-1616 Population-based Phase II Trial of Stereotactic Radiotherapy for up to 5 Oligometastases: SABR-5
EP-1616 Population-based Phase II Trial of Stereotactic Radiotherapy for up to 5 Oligometastases: SABR-5
2019
Robert Olson
Mitchell Liu
A. Bergman
S Lam
Fred Hsu
Benjamin Mou
Tanya Berrang
A Mestrovic
N Chng
D. Hyde
Q Matthews
C. Lund
D. Glick
Howard Pai
Parminder S. Basran
Hannah Carolan
B. Valev
Scott Tyldesley
D Schellenberg
Keywords:
SABR volatility model
stereotactic radiotherapy
Radiology
population based
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]